Revolutionary Anticancer Drug Stops Hepatitis B in Liver Cells: A New Hope in Medical Science

Revolutionary Anticancer Drug Stops Hepatitis B in Liver Cells: A New Hope in Medical Science

Breakthrough: Potential Cure for Hepatitis B on the Horizon A groundbreaking collaboration between memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine, and The Rockefeller University has identified a potential vulnerability in the hepatitis B virus (HBV), offering a beacon of hope for millions suffering from this deadly disease. The research, published in Cell, details … Read more